Bestwall Joint Compound (Georgia-Pacific)

Bestwall joint compound, manufactured by Georgia-Pacific under the Bestwall Gypsum Company brand, was a widely used drywall finishing product sold throughout the United States from 1965 to 1977. Laboratory analysis and litigation records have confirmed that certain formulations of this product contained chrysotile asbestos at concentrations of up to 8% by weight. Workers and homeowners who used or disturbed this material during that period faced potential asbestos fiber exposure, and documented health consequences have resulted in a dedicated legal remedy through the Georgia-Pacific LLC Asbestos Settlement Trust.

Product Description

Bestwall joint compound was a pre-mixed or powder-form finishing material applied to the seams, nail holes, and surface imperfections of gypsum wallboard (drywall) installations. Georgia-Pacific sold the product under its Bestwall Gypsum Company subsidiary, which the company had acquired in the 1960s as part of its expansion into building materials. The compound was marketed to professional contractors and retail consumers alike, and its widespread availability through hardware stores and building supply outlets meant it entered residential, commercial, and institutional construction projects across the country.

The product was used in new construction throughout the 1960s and into the mid-1970s, a period of significant residential and commercial building expansion in the United States. As a result, Bestwall joint compound was applied in millions of homes, offices, schools, and other structures that still stand today. Renovation and demolition of these buildings can disturb intact joint compound and generate new exposures decades after the original application.

Georgia-Pacific discontinued the asbestos-containing formulations of Bestwall joint compound by 1977, consistent with broader industry withdrawal from asbestos-containing construction products following regulatory pressure from the Environmental Protection Agency (EPA) and the Occupational Safety and Health Administration (OSHA).

Asbestos Content

Documented product testing and litigation evidence confirm that Bestwall joint compound contained chrysotile asbestos in concentrations of up to 8% by weight in some formulations produced during the 1965–1977 manufacturing period. Chrysotile, sometimes referred to as “white asbestos,” is the most commercially prevalent form of asbestos and is classified as a known human carcinogen by the International Agency for Research on Cancer (IARC), the National Toxicology Program, and EPA.

Asbestos was incorporated into joint compound formulations during this era primarily as a functional additive. Chrysotile fibers improved the workability, crack resistance, and adhesion of the wet compound, and they helped prevent shrinkage during drying. These performance benefits made asbestos-containing joint compounds commercially attractive to manufacturers throughout the industry during the 1960s and early 1970s.

Under the Asbestos Hazard Emergency Response Act (AHERA) and related EPA guidance, chrysotile-containing building materials are subject to specific handling, abatement, and disposal requirements when found in structures undergoing renovation or demolition. Bestwall joint compound applied between 1965 and 1977 falls within the class of materials that may require professional asbestos inspection before disturbance.

How Workers Were Exposed

Asbestos fiber release from Bestwall joint compound occurred primarily during the mechanical disturbance of the dried material. The manufacturing and application cycle of joint compound created multiple exposure windows across different trades and time periods.

Drywall Finishers (Tapers) faced the most direct and sustained occupational exposure. Sanding dried joint compound to achieve a smooth wall surface generates significant airborne dust. When asbestos-containing compound was sanded—often in enclosed rooms with limited ventilation—chrysotile fibers became airborne and respirable. Tapers working during the 1965–1977 period frequently performed this work without respiratory protection, as the hazard was not broadly communicated to the trades.

Painters applied finishes directly over joint compound surfaces and were present in the same work environments during and after sanding operations. Painters also sanded compound as part of surface preparation and were exposed to residual airborne dust from prior finishing work.

Building Renovation Workers encountered Bestwall joint compound during demolition, remodeling, and repair activities. Cutting, grinding, chipping, or breaking drywall assemblies in structures built between 1965 and 1977 can release asbestos fibers from the intact compound at seams and nail holes. This exposure pathway remains active in buildings where original construction materials have not been abated.

DIY Homeowners represent a distinct second-wave exposure population. Many homeowners undertook their own drywall repair, patching, and renovation work in homes constructed with Bestwall products during the relevant period. Consumer-level exposure often occurred without any awareness of the asbestos content, without industrial hygiene controls, and in residential environments shared with family members—creating potential bystander exposure for spouses and children.

OSHA’s permissible exposure limit (PEL) for asbestos is 0.1 fibers per cubic centimeter (f/cc) as an eight-hour time-weighted average, with an excursion limit of 1.0 f/cc for any 30-minute period. Industrial hygiene studies of dry sanding operations involving asbestos-containing joint compounds have documented airborne fiber concentrations capable of exceeding these thresholds under realistic work conditions.

Diseases documented in exposed individuals include mesothelioma, asbestosis, lung cancer, and other asbestos-related conditions. Latency periods for mesothelioma typically range from 20 to 50 years, meaning individuals exposed to Bestwall joint compound during the 1960s and 1970s may be receiving diagnoses today.

Georgia-Pacific established the Georgia-Pacific LLC Asbestos Settlement Trust to resolve asbestos personal injury claims arising from its products, including Bestwall joint compound. The trust was created through bankruptcy proceedings involving Bestwall LLC, a subsidiary Georgia-Pacific established to manage its asbestos liabilities. The trust operates under a Trust Distribution Procedure (TDP) that governs claim eligibility, documentation requirements, and payment determinations.

Eligible claimants include individuals diagnosed with an asbestos-related disease who can demonstrate exposure to Bestwall joint compound or other Georgia-Pacific asbestos-containing products. Claims may be filed on behalf of deceased individuals by surviving family members or estate representatives.

Claim categories under the trust’s TDP generally include:

  • Mesothelioma — the highest-tier disease category, reflecting the severity and near-universal causal link to asbestos exposure
  • Lung Cancer — eligible with documented asbestos exposure history and, in most TDP frameworks, evidence of an asbestos-related condition
  • Asbestosis and Other Asbestos-Related Diseases — evaluated based on documented medical findings and exposure evidence

Supporting documentation typically required includes medical diagnosis records, occupational or product exposure history, employment records, sworn affidavits from the claimant or coworkers, and, where applicable, product identification evidence linking the claimant to Bestwall joint compound specifically.

Individuals who believe they were exposed to Bestwall joint compound and have received an asbestos-related diagnosis should consult an attorney experienced in asbestos trust fund litigation. Filing deadlines and eligibility criteria are governed by the trust’s TDP and may be subject to change. An asbestos attorney can evaluate whether claims may also exist against other parties, as many jobsites involved products from multiple manufacturers.

This article is provided for informational and reference purposes. It documents a specific asbestos-containing product based on publicly available litigation, regulatory, and trust fund records. It does not constitute legal advice.